|
Time |
Source |
|
Announcement
|
|
14 Jan 2021 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19 |
13 Jan 2021 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study |
16 Dec 2020 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week |
10 Dec 2020 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Announces the Approval of the T-Cell Select™ Reagent Kit, Used to Automate the T-SPOT®.TB Test Workflow, for IVD Use in South Korea |
02 Dec 2020 |
2:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Signs Exclusive Distributor Agreement with RIKEN Genesis, a Subsidiary of Sysmex, to Market the T-SPOT® Discovery SARS-CoV-2 Kit for the Measurement of the T cell Immune Response to SARS-CoV-2 Infection in Japan |
23 Nov 2020 |
12:30 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec to Hold a Virtual Investor Event on December 17, 2020 |
10 Nov 2020 |
2:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Data Showing SARS-CoV-2 Reactive T Cells are Associated with Protection from COVID-19 – and Can Be Both Detected and Measured Using Oxford Immunotec’s T-SPOT® Technology – is Published by Public Health England and Oxford Immunotec |
05 Nov 2020 |
2:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Files Submission to Food and Drug Administration (FDA) for the T-Cell Select™ Reagent Kit |
03 Nov 2020 |
12:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Reports Third Quarter 2020 Financial Results |
22 Oct 2020 |
10:30 am |
GNW
|
|
|
Oxford Immunotec Global PLC |
UK Vaccines Taskforce has Selected Oxford Immunotec as the Sole Supplier of T cell Testing for SARS-CoV-2 Specific Responses in New COVID Vaccine Trials |
21 Oct 2020 |
9:05 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Schedules Third Quarter 2020 Earnings Release and Conference Call for November 3, 2020 |
22 Sep 2020 |
2:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery™ SARS-CoV-2 Test |
04 Aug 2020 |
12:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Reports Second Quarter 2020 Financial Results |
21 Jul 2020 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Schedules Second Quarter 2020 Earnings Release and Conference Call for August 4, 2020 |
20 Jul 2020 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Announces Agreement with Stop TB Partnership - Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries |
19 May 2020 |
10:00 am |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2, which may offer new insights into immunity to COVID-19 |
05 May 2020 |
12:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Reports First Quarter 2020 Financial Results |
29 Apr 2020 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Schedules First Quarter 2020 Earnings Release and Conference Call for May 5, 2020 |
21 Apr 2020 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec announces successful re-registration of the T-SPOT®.TB test in China |
02 Mar 2020 |
12:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Reports Fourth Quarter and Full Year 2019 Financial Results |
27 Feb 2020 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec to Present at the Cowen and Company 40th Annual Health Care Conference |
24 Feb 2020 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for March 2, 2020 |
20 Feb 2020 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Announces New Data on the Utility of T-SPOT®.CMV in Kidney and Stem Cell Transplant |
23 Jan 2020 |
9:00 am |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Announces Donation in Support of Coronavirus Testing Efforts to Help Differentiate Tuberculosis from the New China Virus |
06 Jan 2020 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec to Present at the 38th Annual J.P. Morgan Healthcare Conference |
25 Nov 2019 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec to Participate in Two Investor Conferences |
05 Nov 2019 |
12:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Reports Third Quarter 2019 Financial Results |
22 Oct 2019 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Schedules Third Quarter 2019 Earnings Release and Conference Call for November 5, 2019 |
21 Aug 2019 |
2:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec to Participate in Two Upcoming Investor Conferences |
06 Aug 2019 |
12:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Reports Second Quarter 2019 Financial Results |
18 Jul 2019 |
8:35 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019 |
24 Jun 2019 |
4:35 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman |
17 May 2019 |
2:25 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel |
14 May 2019 |
2:20 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec to Present at the UBS Global Healthcare Conference |
09 May 2019 |
12:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Reports First Quarter 2019 Financial Results |
25 Apr 2019 |
9:05 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Schedules First Quarter 2019 Earnings Release and Conference Call for May 9, 2019 |
28 Mar 2019 |
11:45 am |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Announces New Initiative to Bring the Benefit of Modern Tuberculosis Testing to the Russian Federation |
21 Mar 2019 |
8:01 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Announces Chief Financial Officer Transition |
11 Mar 2019 |
8:10 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Reports Fourth Quarter and Full Year 2018 Financial Results |
05 Mar 2019 |
2:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec to Participate in Two Upcoming Investor Conferences |
19 Feb 2019 |
9:45 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for March 11, 2019 |
07 Jan 2019 |
12:00 am |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Announces Board Approval of $100 Million Share Repurchase Program and Reaffirms Growth Expectations for Fourth Quarter 2018 |
02 Jan 2019 |
2:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec to Present at the 37th Annual J.P. Morgan Healthcare Conference |
07 Dec 2018 |
2:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select in China |
26 Nov 2018 |
10:31 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec to Participate in Two Investor Conferences This Week |
09 Nov 2018 |
12:15 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Reports Third Quarter 2018 Financial Results |
06 Nov 2018 |
10:12 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Schedules Third Quarter 2018 Earnings Release and Business Update Conference Call for November 9, 2018 |
31 Jul 2018 |
12:00 pm |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Reports Second Quarter 2018 Financial Results |
|
11:55 am |
GNW
|
|
|
Oxford Immunotec Global PLC |
Oxford Immunotec Launches T-Cell Select to Enable Full Automation of the T-SPOT®.TB Test, Provides Unrivaled Sample Stability and Simplicity of Blood Collection |